Coherus Oncology Inc. (CHRS)
NASDAQ: CHRS
· Real-Time Price · USD
1.50
0.05 (3.45%)
At close: Sep 26, 2025, 3:59 PM
1.49
-0.67%
After-hours: Sep 26, 2025, 06:58 PM EDT
Coherus Oncology Revenue
Coherus Oncology reported an annual revenue of $266.96M, reflecting a 3.78% growth. For the quarter ending June 30, 2025, Coherus Oncology generated $10.25M in revenue.
Revenue (ttm)
266.96M
Revenue Growth
3.78%
Price / Sales Ratio
0.59
Revenue / Employee
1.17M
Employees
228
Market Cap
174.34M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 266.96M | +3.78% |
| Dec 31, 2023 | 257.24M | +21.89% |
| Dec 31, 2022 | 211.04M | -35.37% |
| Dec 31, 2021 | 326.55M | -31.37% |
| Dec 31, 2020 | 475.82M | +33.63% |
| Dec 31, 2019 | 356.07M | +22783.74% |
| Dec 31, 2018 | 1.56M | n/a |
| Dec 31, 2017 | 1.56M | -99.18% |
| Dec 31, 2016 | 190.11M | +532.82% |
| Dec 31, 2015 | 30.04M | -3.42% |
| Dec 31, 2014 | 31.11M | +1030.72% |
| Dec 31, 2013 | 2.75M | +44.87% |
| Dec 31, 2012 | 1.9M | n/a |